The
Peter Marks, who was a key figure in Operation Warp Speed, stepped down from his position as the director of the FDA’s Center for Biologics Evaluation and Research, which is responsible for the safety and effectiveness of vaccines, along with gene therapies and blood products.
“I was willing to work to address the Secretary’s concerns regarding vaccine ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
